Frosch DL, Kaplan RM (1999) Shared decision making in clinical medicine: Past research and future directions. Am J Prev Med 17: 285–294.
[2]
Briss P, Rimer B, Reilley B, Coates RC, Lee NC, et al. (2004) Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med 26: 67–80.
[3]
Elwyn G, Edwards A, Gwyn R, Grol R (1999) Towards a feasible model for shared decision making: Focus group study with general practice registrars. BMJ 319: 753–756.
[4]
McKinstry B (2000) Do patients wish to be involved in decision making in the consultation? A cross-sectional survey with video vignettes. BMJ 321: 867–871.
[5]
Say RE, Thomson R (2003) The importance of patient preferences in treatment decisions-Challenges for doctors. BMJ 327: 542–545.
[6]
Braddock CH, Edwards KA, Hasenberg NM, Laidley TL, Levinson W (1999) Informed decision making in outpatient practice: Time to get back to basics. JAMA 282: 2313–2320.
[7]
Wilkes MS, Bell RA, Kravitz RL (2000) Direct-to-consumer prescription drug advertising: Trends, impact, and implications. Health Aff (Millwood) 19: 110–128.
[8]
von Neumann J, Morgenstern O (1967) Theory of games and economic behavior.New York: J. Wiley. 641. 3rd edition.
[9]
Drummond MF, Stoddart GL, Torrance GW (1997) Methods for the economic evaluation of health care programmes.Oxford: Oxford University Press. 379. 2nd edition.
[10]
Read JL, Quinn RJ, Berwick DM, Fineberg HV, Weinstein MC (1984) Preferences for health outcomes: Comparisons of assessment methods. Med Decis Making 4: 315–329.
[11]
Edwards A, Elwyn G, Mulley A (2002) Explaining risks: Turning numerical data into meaningful pictures. BMJ 324: 827–830.
[12]
Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA (2004) SEER Cancer Statistics Review, 1975–2002.Bethesda (Maryland): National Cancer Institute. Available: http://seer.cancer.gov/csr/1975_2002. Accessed 26 April 2006.
[13]
Harris R, Lohr KN (2002) Screening for prostate cancer: An update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137: 917–929.
[14]
Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P, et al. (2002) A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347: 781–789.
[15]
Lipkus IM, Hollands JG (1999) The visual communication of risk. J Natl Cancer Inst Monogr 25: 149–163.
[16]
Elting LS, Martin CG, Cantor SB, Rubenstein EB (1999) Influence of data display formats on physician investigators' decisions to stop clinical trials: Prospective trial with repeated measures. BMJ 318: 1527–1531.
[17]
Gigerenzer G, Edwards A (2003) Simple tools for understanding risks: From innumeracy to insight. BMJ 327: 741–744.
[18]
Paling J (2003) Strategies to help patients understand risks. BMJ 327: 745–748.
[19]
Barratt A, Trevena L, Davey HM, McCaffery K (2004) Use of decision aids to support informed choices about screening. BMJ 329: 507–510.
